Macrogenics Inc (MGNX)
3.715
-0.16
(-4.01%)
USD |
NASDAQ |
Nov 04, 13:07
Macrogenics Shareholders Equity (Quarterly): 57.82M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 57.82M |
| March 31, 2024 | 106.15M |
| December 31, 2023 | 152.61M |
| September 30, 2023 | 193.98M |
| June 30, 2023 | 171.54M |
| March 31, 2023 | 109.27M |
| December 31, 2022 | 142.01M |
| September 30, 2022 | 122.96M |
| June 30, 2022 | 142.48M |
| March 31, 2022 | 178.21M |
| December 31, 2021 | 239.62M |
| September 30, 2021 | 291.44M |
| June 30, 2021 | 319.04M |
| March 31, 2021 | 350.53M |
| December 31, 2020 | 295.88M |
| September 30, 2020 | 291.58M |
| June 30, 2020 | 247.78M |
| March 31, 2020 | 190.57M |
| December 31, 2019 | 230.63M |
| September 30, 2019 | 255.20M |
| June 30, 2019 | 294.45M |
| March 31, 2019 | 320.62M |
| December 31, 2018 | 242.88M |
| Date | Value |
|---|---|
| September 30, 2018 | 282.64M |
| June 30, 2018 | 312.04M |
| March 31, 2018 | 247.28M |
| December 31, 2017 | 299.24M |
| September 30, 2017 | 189.46M |
| June 30, 2017 | 231.35M |
| March 31, 2017 | 234.64M |
| December 31, 2016 | 268.75M |
| September 30, 2016 | 300.10M |
| June 30, 2016 | 329.98M |
| March 31, 2016 | 286.26M |
| December 31, 2015 | 313.34M |
| September 30, 2015 | 339.33M |
| June 30, 2015 | 211.69M |
| March 31, 2015 | 230.99M |
| December 31, 2014 | 121.29M |
| September 30, 2014 | 139.09M |
| June 30, 2014 | 141.98M |
| March 31, 2014 | 153.22M |
| December 31, 2013 | 78.91M |
| September 30, 2013 | -4.048M |
| June 30, 2013 | -10.93M |
| December 31, 2012 | -8.237M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
57.82M
Minimum
Jun 2024
350.53M
Maximum
Mar 2021
201.80M
Average
190.57M
Median
Mar 2020
Shareholders Equity (Quarterly) Benchmarks
| Zimmer Biomet Holdings Inc | 12.37B |
| Penumbra Inc | 1.104B |
| Apellis Pharmaceuticals Inc | 264.33M |
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 201.14M |
| Total Liabilities (Quarterly) | 143.32M |
| Current Ratio | 2.710 |